Revolution Acceleration Acquisition filed to raise up to $250 million in an IPO. The new SPAC is targeting companies in technology, government policy, and regulation.
Revolution Acceleration plans to list on the Nasdaq under RAACU. Read more.
4D pharma received the $14.6 million cash held by Longevity. In addition, 4D pharma gains the proceeds of warrants to purchase Longevity shares worth up to $23 million.
The SPAC’s focus is on US companies within the tech industry. Trailblazer initially registered in July to raise $67.5 million, downsizing the offering in January before today's float.
The SPAC intends to search for a target business in the transportation field, including logistics, new energy vehicles, smart parking, on-board chips and AI algorithms, automotive services and related areas of intelligent transportation.